SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 11, 2001
BIO-VASCULAR, INC.
(Exact name of registrant as specified in its charter)
Minnesota 0-13907 41-1526554
- ---------------------------- ------------ -------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
2575 University Avenue
St. Paul, Minnesota 55114
--------------------------- --------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (651)603-3700
-------------
Item 4. Changes in Registrant's Certifying Accountants.
On May 10, 2001, Bio-Vascular, Inc. (the "Company") appointed Deloitte
and Touche LLP as its independent auditors for the fiscal year ending October
31, 2001. Such engagement was approved by the Company's Audit Committee of the
Board of Directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: May 11, 2001
BIO-VASCULAR, INC.
By: /s/ Connie L. Magnuson
-----------------------------
Connie L. Magnuson
Vice President of Finance and
Chief Financial Officer
2